"Save enough money" to prevent cancer! Can stem cell storage eliminate cancer? Doctor: It's best to treat the two types of people as early as possible
Cryopreservation is promoting health. Stem cell storage is expected to become a cancer prevention trend.
The Ministry of Health and Welfare recently released statistics on causes of death in Taiwan in 2019. Among them, malignant tumors (cancer) have been the number one cause of death for 40 consecutive years. Cancer chemotherapy can easily cause damage to healthy cells or tissues, leading to a decrease in the patient’s immunity, resulting in physical exhaustion, sepsis, infection or cancer metastasis, which is one of the causes of more than 90% of cancer deaths.
Among various emerging therapeutic weapons, storing one’s own stem cells can be used to renew and repair various tissues and organs. There are also many successful cases of anti-cancer and cancer suppression around the world, becoming a rising wave of medical technology in recent years.
In fact, about 10% of cancers and chronic diseases are highly heritable. Professor Lin Kaixin, an authoritative physician on pediatric hematology and oncology at National Taiwan University Hospital, said, “Cryopreservation of healthy stem cells and infusing healthy stem cells back into the body can balance the elimination of diseased cells in the body and renew aging damage.” Cells. “Whether it is a highly familial genetic problem of chronic disease or a cancer problem that may be faced in the future, it is recommended to store peripheral blood stem cells early to prepare for an additional option when needed.
What are the differences in stem cell storage types? The first choice for low-invasive prevention is this
Stem cell storage is the key to stem cell therapy. Currently, there are various types of storage methods. There are four most common types of stem cell storage: umbilical cord blood, bone marrow, peripheral blood, and fat. Among them, “peripheral blood stem cells” have relatively obvious benefits, including:
Low invasiveness and short extraction time: It is the least invasive storage method. The whole process only takes 3-4 hours to complete the extraction of peripheral blood stem cells.
The first choice for family history and cancer prevention: The storage of peripheral blood stem cells is crucial for people with family genetic diseases, family history of cancer, or those who have been diagnosed with cancer. Multiple recent research papers have shown that peripheral blood stem cells, whether autologous or allogeneic, have been widely used clinically to treat blood-related cancers such as lymphoma and so on. A 2021 comprehensive research analysis paper pointed out that if autologous peripheral blood stem cells are used to treat lymphoma, there will be a higher survival rate.
Store stem cells early to maintain activity and prepare for the best health prevention
Ivy Biotechnology, which specializes in the field of stem cell storage in Taiwan, shared that from the latest papers published in 2021, it can be found that although there is no age limit for the extraction of adult peripheral blood stem cells, the older you are, the poorer the quality of stored peripheral blood stem cells. , the smaller the number, the better way to store healthy stem cells as early as possible.
Professor Lin Kaixin reminded that it is recommended to store peripheral blood stem cells as early as possible, whether it is a group with a history of chronic diseases or for early deployment to deal with future cancer risks. Not only do your own young cells have the highest activity, highest compatibility, and lowest rejection, but you will be prepared in advance when you need to use them in the future, so you will not face the situation of “no stem cells for treatment.”
Ask the Experts
Professor Lin Kaixin, an authoritative physician in the Pediatric Department of National Taiwan University Hospital and the host of the Ivy Biotechnology R&D Center
Learning Experience
- Honorary Professor, National Taiwan University School of Medicine
- Attending Physician of the Department of Pediatrics/Director of the Department of Hematology and Oncology of the Department of Pediatrics, National Taiwan University Hospital
- Honorary Chairman of Taiwan Thalassemia Association
- Served as Vice President of E-Da Hospital
- Served as Chairman of the Taiwan Society of Blood and Marrow Transplantation
- Graduated from Department of Medicine, National Taiwan University
Medical Expertise
Stem cell transplantation, hematology-oncology, cell therapy, stem cell storage, congenital genetic diseases
Further reading:
Major trends in medical technology in the post-epidemic era: Accelerating the application of stem cell therapy, Taiwan enters a golden decade!
